Skip to main content
. 2021 Dec 1;31(2):342–351. doi: 10.1158/1055-9965.EPI-21-0555

Figure 4.

Figure 4. Recurrence and survival estimates for patients diagnosed with nonmetastatic disease during 2007 to 2016. RFS is presented for RCC (blue) versus LCC (red) in patients aged 0 to 74 (A) and ≥75 (B) years. SAR is presented for RCC (blue) versus LCC (red) in patients aged 0 to 74 (C) and ≥75 (D) years. HRs are unadjusted, comparing LCC with RCC (reference).

Recurrence and survival estimates for patients diagnosed with nonmetastatic disease during 2007 to 2016. RFS is presented for RCC (blue) versus LCC (red) in patients aged 0 to 74 (A) and ≥75 (B) years. SAR is presented for RCC (blue) versus LCC (red) in patients aged 0 to 74 (C) and ≥75 (D) years. HRs are unadjusted, comparing LCC with RCC (reference).